WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest…
WASHINGTON, D.C. – To ensure production of vital medical devices and diagnostic tests during this critical time and to help prevent future supply chain issues, the Advanced Medical Technology Association® (AdvaMed®) announced that…
AdvaMed® announced that shipments of COVID-19 molecular diagnostic tests reached one million per day for the week ending July 24, based on the latest data from the association’s National Testing Registry.
Whitaker Calls National Registry “Crucial Tool” for Federal, State Authorities; Announces More Than 65 Million Tests Shipped Nationwide Since Beginning of Pandemic WASHINGTON, D.C. – In its latest action to help ensure…
WASHINGTON, D.C. – In its latest action to help ensure the widespread availability of testing to detect and contain the coronavirus, the Advanced Medical Technology Association® (AdvaMed®) today announced the creation of…
WASHINGTON, D.C. – AdvaMed® today sent the following letter to Health and Human Services (HHS) Secretary Azar requesting that he extend the declared federal public health emergency (PHE) beyond its current…
WASHINGTON, D.C. – Today, 340 organizations signed a letter urging Congressional leaders to make telehealth flexibilities created during the COVID-19 pandemic permanent. Those signing this multi-stakeholder letter include national and…
WASHINGTON, D.C. – The Medtech Conference, powered by AdvaMed®, promises to continue its tradition of providing world-class programming for the medical technology community, announcing today that the conference will be…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®), the Association of periOperative Registered Nurses (AORN), and the American Hospital Association (AHA) today announced 26 additional health care professional societies and…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today released the following statement from Susan Van Meter, executive director of AdvaMedDx®, in response to comments on COVID-19 serology/antibody testing at today’s hearing…